Latest "Line Management" News Stories

08:52 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Line Management" found in our extensive news archives from over 250 global news sources.

More Information about Line Management on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Line Management for you to read. Along with our medical data and news we also list Line Management Clinical Trials, which are updated daily. BioPortfolio also has a large database of Line Management Companies for you to search.

Showing "Line Management" News Articles 1–25 of 11,000+


#jobs #lifescience SRG: Senior Analytical Chemist (Line Manager)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: SRG: Senior Analytical Chemist (Line Manager) . DOE: SRG: Senior Analytical Chemist (Line Manager)Role Type: PermanentLocation: CambridgeSalary: Competitive (DOE)Skills: Line Management, Team Leader, HPLC, Me Cambridge, England from … Continue reading → Cet article...

Mardi Gras Selected As Name For Largest Carnival Cruise Line Ship Ever Constructed

MIAMI, Dec. 5, 2018 /PRNewswire/ -- In a nod to Carnival Cruise Line's rich history as America's Cruise Line, the line announced today that it Read more...

Radical shifts in the first-line management of metastatic renal cell carcinoma

Klox Technologies announces positive top-line results from a pivotal study of Phovia™ for the management of Canine Deep Pyoderma

DUBLIN, Ireland, July 02, 2018 (GLOBE NEWSWIRE) -- Klox Technologies Limited, a subsidiary of Klox Technologies Inc. (‘KTI’) has announced they have completed a pivotal study of Phovia for the management of Canine Deep Pyoderma. The 80-patient study met all endpoints and demonstrated that Phovia significantly reduces time to clinical resolution while reducing the duration of antibiotic use...

RNase H2, mutated in Aicardi-Goutieres syndrome, promotes LINE-1 retrotransposition

Long INterspersed Element class 1 (LINE-1) elements are a type of abundant retrotransposons active in mammalian genomes. An average human genome contains ~100 retrotransposition-competent LINE-1s, whose activity is influenced by the combined action of cellular repressors and activators. TREX1, SAMHD1 and ADAR1 are known LINE-1 repressors and when mutated cause the autoinflammatory disorder Aicardi...

Medical News Today: What to do about an evaporation line on a pregnancy test

An evaporation line on a pregnancy test is a faint, non-colored line that may appear if a person uses the test incorrectly. In this article, learn to tell the difference between an evaporation line and a positive test result. We also describe how pregnancy tests work and how to prevent evaporation lines from appearing.

Health Management Systems Adds wayForward to its Wellbeing Technology Suite

DETROIT (PRWEB) November 06, 2018 Health Management Systems of America (HMSA), a national EAP and Wellbeing service provider announced that it will be adding the, wayForward app to its suite of technology services. Following the development of On-line Counseling functionality, Text Chat porta...

StatPro Group (158355634SOG) - In-line trading, underpinned by Infovest contract

Edison Investment Research - Technology - StatPro Group: In an in-line Q3 trading update, StatPro says that its annualised recurring revenue (ARR) rose by 3% at constant currencies over the past 12 months to £54.8m. Additionally, earlier this week StatPro announced a c £1.0m five-year Infovest contract, which highlights the quality of the group’s Infovest data management solution...

Carclo (158355634CAR) - FY19 expectations unchanged despite slow first half

Edison Investment Research - Technology - Carclo: Carclo has announced that three new medical programmes were delayed by customers during H119 and that while these programmes had all entered production successfully by the end of the period, the delays resulted in H119 underperformance for the Technical Plastics division (CTP). Although the LED division performed in line with management’s exp...

Osirium Technologies (158355634OSI) - Securing growth through PAM innovation

Edison Investment Research - Technology - Osirium Technologies: Osirium reported H118 results in line with management expectations. Revenue growth of 78% and bookings growth of 37% provide good support to our FY18 forecasts. Heightened M&A activity in the privileged access management (PAM) market highlights the growing importance of PAM technology in IT security and the greenfield opportunity ...

Dechra hikes dividend as acquisitions boost annual revenues

Dechra said the new financial year has started well and in line with management’s expectations.

EU approves first-line use of AZ’ Tagrisso in lung cancer

AstraZeneca’s Tagrisso has been given a green light in Europe for first-line use to treat EGFR-mutated non-small cell lung cancer (NSCLC), offering a new line of attack at this stage of the disease.

Dechra shares plunge despite 2018 revenue and profit growth as it warns on risks

Dechra said the new financial year has started well and in line with management’s expectations.

There’s a fine line between stupid and clever in medicine

In the 1984 rock mockumentary This is Spinal Tap, a fictional band discusses the controversy surrounding one of their album covers. “There’s such a fine line between stupid and …” the lead singer says, realizing where they’d crossed the line of tastefulness. His guitarist finishes his thought, “… and clever,” he says. In life, in […]

Morgan Stanley reckons new Smith & Nephew boss can “reinvigorate” artificial hip maker

“We upgrade to ‘overweight’ on the basis that, following several years of stagnation, new management should help reinvigorate top-line performance”

Max 21 (158355634MA1) - Appetite for more growth

Edison Investment Research - Technology - Max 21: Max 21 continues its successful turnaround story, with a solid increase in H118 sales related to Binect family products and LinOTP (even if somewhat behind management expectations). Encouraged by the top-line growth and recently introduced cost efficiencies, management has reaffirmed its FY18 revenue guidance at €7m (implying a 27% y-o-y growt...

CLL Sector Heats Up, AbbVie/Roche Upbeat About First-Line Venetoclax Combo

Positive top-line data on use of an AbbVie/Genentech's venetoclax combination as a first-line chronic lymphocytic leukemia therapy heralds stiffer competition...   

First-Line ART With EFV or RPV Plus TDF/FTC

How do these first-line combination antiretroviral therapy regimens compare in terms of tolerance and durability? HIV Medicine

Kristin Ess launches a hair tool line at Target


New Recommendations for Hand Osteoarthritis Released

The 2018 EULAR update on management of hand OA begins with education, exercise, orthoses, and topical NSAIDs as first-line pharmacological treatment. Use of acetaminophen is discouraged. Medscape Medical News

Engrailed homeoprotein blocks degeneration in adult dopaminergic neurons through LINE-1 repression

LINE-1 mobile genetic elements have shaped the mammalian genome during evolution. A minority of them have escaped fossilization which, when activated, can threaten genome integrity. We report that LINE-1 are expressed in substantia nigra ventral midbrain dopaminergic neurons, a class of neurons that degenerate in Parkinson's disease. In Engrailed-1 heterozygotes, these neurons show a progressive d...

Checkpoint Inhibitors Highly Active in Metastatic RCC

A study shows RCC patients overall response rate did not decline from the first‐line to the fourth‐line of IO therapy.

AZ’s Imfinzi combo will struggle to dislodge first-line NSCLC competitors

AstraZeneca is unlikely to find a distinct spot for Imfinzi (durvalumab) combined with tremelimumab in the highly coveted first-line (1L) non-small-cell...Read More... The post AZ’s Imfinzi combo will struggle to dislodge first-line NSCLC competitors appeared first on Pharmaceutical Technology.

ASCO 2018: Merck’s Keytruda on top in first-line NSCLC

The much-anticipated latest installment of the first-line non-small cell lung cancer (NSCLC) battle took place at this year’s American Society...Read More... The post ASCO 2018: Merck’s Keytruda on top in first-line NSCLC appeared first on Pharmaceutical Technology.

Sarine Technologies (U77) - Cost reductions driving profitability

Edison Investment Research - General Industrials - Sarine Technologies: Sarine’s prudent cost management in Q218 translated into a 12.4% y-o-y increase in EBIT to US$4.7m, despite the lack of top-line growth. The company continues to focus on increasing the recurring revenue streams from retail-oriented services led by Sarine Profile and the 4Cs grading reports, with its second technology la...

Quick Search


News Quicklinks